OTC Obesity - Denmark

Date: April 22, 2010
Pages: 29
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OC3C97A4E03EN
Leaflet:

Download PDF Leaflet

The product category was switched to OTC status in May 2009. There is much public focus on the dangers and growing problem of obesity in Denmark. Consumers therefore showed keen interest in this first medically approved remedy for obesity available without prescription, and sales came off to a good start, reaching DKr2 million by the end of 2009, after only seven months on the market.

Euromonitor International's OTC Obesity Products in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage:

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
OTC Obesity in Denmark
Euromonitor International
April 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Health Concerns Were the Key Growth Driver
Competitive Pricing and Wide Distribution Proved Key To Success in 2009
Strong Trend Towards Grocery Retailers
Stagnant Value Sales Forecast
Key Trends and Developments
Liberalization Underpinned Strong Trend Towards Grocery Retailers
Health Concerns was the Key Driver of Consumer Healthcare Demand
Consolidation Strategies Began To Bear Fruit
Dynamic Growth in Internet Retailing
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Penetration of Private Label by Sector 2004-2009
  Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 1 OTC Healthcare Switches 2007-2009
Definitions
  Summary 2 Research Sources
Actavis Nordic A/S
Strategic Direction
Key Facts
  Summary 3 Actavis Nordic A/S: Key Facts
Company Background
Production
Competitive Positioning
  Summary 4 Actavis Nordic A/S: Competitive Position 2009
Axellus A/S
Strategic Direction
Key Facts
  Summary 5 Axellus A/S: Key Facts
  Summary 6 Axellus A/S: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 7 Axellus A/S: Competitive Position 2009
Ferrosan A/S
Strategic Direction
Key Facts
  Summary 8 Ferrosan A/S: Key Facts
  Summary 9 Ferrosan A/S: Operational Indicators
Company Background
Competitive Positioning
  Summary 10 Ferrosan A/S: Competitive Position 2009
Nycomed Danmark A/S
Strategic Direction
Key Facts
  Summary 11 Nycomed Danmark A/S: Key Facts
  Summary 12 Nycomed Danmark A/S: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 13 Nycomed Danmark A/S: Competitive Position 2009
Orifarm A/S
Strategic Direction
Key Facts
  Summary 14 Orifarm A/S: Key Facts
  Summary 15 Orifarm Group: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 16 Orifarm A/S: Competitive Position 2009
Trends
Category Data
  Table 12 Sales of OTC Obesity: Value 2009
  Table 13 OTC Obesity Company Shares by Value 2005-2009
  Table 14 OTC Obesity Brand Shares by Value 2006-2009
  Table 15 Forecast Sales of OTC Obesity: Value 2009-2014
  Table 16 Forecast Sales of OTC Obesity: % Value Growth 2009-2014
Skip to top


OTC Obesity - Australia US$ 990.00 Jun, 2010 · 33 pages
OTC Obesity - Austria US$ 990.00 Apr, 2010 · 31 pages
OTC Obesity - France US$ 990.00 Apr, 2010 · 49 pages
OTC Obesity - Greece US$ 990.00 Mar, 2010 · 33 pages
OTC Obesity - Netherlands US$ 990.00 Jun, 2010 · 32 pages

Ask Your Question

OTC Obesity - Denmark
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: